 Low-dose co-trimoxazole prevention Pneumocystis carinii pneumonia human immunodeficiency virus efficacy tolerability low intermittent doses co-trimoxazole mg trimethoprim mg sulfamethoxazole Monday Wednesday Friday prophylaxis Pneumocystis carinii pneumonia PCP patients acquired immunodeficiency syndrome AIDS AIDS-related complex high risk PCP concomitant zidovudine previous episode PCP mean months past PCP depletion cells mean months patient co-trimoxazole side-effects rash pruritus nausea discontinued co-trimoxazole first month drug-intolerant low-dose thrice weekly co-trimoxazole AIDS-associated PCP cost-effective patients Controlled comparisons regimen prophylactic agents